Organs of transgenic pigs that express human complement regulatory proteins are under assessment as an alternative to transplantation. A major barrier to the transplantation of pig organs is the hyperacute rejection caused by pre-existing antibodies and complement. Pig cells are very susceptible to human complement, presumably because pig cell-surface complement regulatory proteins are inefficient against it. Expression of human complement regulatory proteins, such as decay-accelerating factor and membrane cofactor proteins (MCP or CD46), by means of transgenes would confer resistance to human complement upon pig cells, thereby preventing hyperacute rejection. To express sufficient levels of human complement regulatory proteins at appropriate sites, regulatory elements of genes of pig membrane-bound complement regulatory proteins would be useful. To obtain their cDNAs, we transfected human cells with a pig cDNA library, selected cells by incubation with pig complement and rescued the plasmids. We cloned a cDNA for the pig homologue of MCP, pMCP. The cDNA encoded a predicted protein of 363 amino acids with 42% amino acid identity with human MCP. The pMCP consisted of four short consensus repeats, a Ser/Thr/Pro-rich domain, and transmembrane and cytoplasmic domains. Recombinant soluble pMCP that lacked transmembrane and cytoplasmic domains had factor I cofactor activity in C3b cleavage, indicating that it is functionally, as well as structurally homologous to MCP. FACS analysis with anti-pMCP mAb demonstrated that pMCP is expressed on all blood leukocytes, erythrocytes, and on endothelial and epithelial cell lines.
Introduction
Host cells are protected from their own complement (7-9) and are being used as models of pig to primate transplantation. by membrane-bound complement regulatory proteins. In humans, decay-accelerating factor (DAF or CD55), memWe reasoned that regulatory elements of genes of porcine membrane-bound complement regulatory proteins would be brane cofactor protein (MCP or CD46) and CD59 perform this function. The hyperacute rejection caused by preformed useful for expressing human complement regulatory proteins in proper sites of pig organs at sufficient levels. However, little antibodies and complement is a major barrier to the transplantation of pig organs to humans (1) (2) (3) . In contrast is known about these genes and their products. Pig CD59 protein has been purified but its gene has not been cloned to human cells, those of the pig are very susceptible to human complement, presumably because pig cell-surface (10,11).
In the present investigation we constructed an expression complement regulatory proteins are ineffective against human complement. The expression of human complement cloning system to obtain cDNAs of membrane-bound pig complement regulatory proteins. We transfected human cells with regulatory proteins by means of transgenes would confer resistance to human complement upon pig cells (4) (5) (6) .
a pig cDNA library, selected transfectants with activated pig complement and rescued cDNAs from the surviving cells. We Transgenic pigs that express human complement regulatory proteins, such as DAF, MCP or CD59, have been generated cloned a cDNA of pig homologue of MCP (pMCP).
Methods

RT-PCR analysis of the 3Ј region of pMCP
The first strand cDNA was prepared from total RNA of PAE Cells and antibodies cells with using Superscript II (Stratagene) and the primer 5Ј-The PAE cell line (porcine aortic endothelial cell line) was a CGT GGA TTC AGT GAT GAT TTA ATT CA-3Ј (complementary gift from Dr K. Miyazono (12,13). An Epstein-Barr virusto the 3Ј untranslated region). A region of pMCP was amplified transformed human B lymphoblastoid cell line JY25 (14) was by PCR (94°C for 5 min at first cycle and 94°C for 40 s, 60°C a gifts from Dr Moon L. Shin. Anti-human MCP mAb (M-75) for 30 s and 72°C for 2 min for 30 cycles and 72°C for 5 min) was a gift from Drs Tsukasa Seya and Misako Matsumoto using the sense primer 5Ј-ATG CAA TGC TGG TTT TAC CCT (15). Anti-HLAI mAb (W6/32) (16), anti-Myc mAb (9E10) TCA-3Ј corresponding to a region in the fourth SCR and the (17) and a porcine kidney epithelial cell line LLC-PK1 were antisense primer 5Ј-GTA GAG ACA AAA TCA TGC GTT TAG purchased from ATCC (Rockville, MD).
G-3Ј corresponding to a region in the 3Ј untranslated region.
Construction of plasmids and a cDNA library Preparation of recombinant soluble pMCP (rspMCP) A 5.6 kb SfiI fragment containing the Epstein-Barr virus origin
The BmN4 cell line derived from the silkworm Bombyx mori of replication (ori P) and the hygromycin phosphotransferase was obtained from Nosannkoh (Kanagawa, Japan) and maingene (hph), but not EBNA-1 gene, was isolated from EBOtained in TC-100 medium (Gibco/BRL, Gaithersburg, MD) pSV2-neo as described previously (18). It was subcloned into with 10% FCS (24) . To construct recombinant virus, a region the SfiI site of pME18Sfϩ (a gift from Dr K. Maruyama) to corresponding to nucleotides 1-1042 of pMCP was amplified generate pME18Sfϩ(ϩori P) (19). A cDNA library was preby PCR. An ApaI restriction site and the Myc-tag sequence pared from poly(A) ϩ RNA of the PAE cell line as described were introduced into the forward primer. A stop codon and a by Tanaka et al. (20) , except that the SalI-SmaI adaptor NotI site were introduced into the reverse primer. The amplified (Stratagene, La Jolla, CA) was used instead of the BglI-SmaI product was subcloned into the pBSIIKSϩ plasmid and its adaptor. The cDNAs were directionally inserted between the sequence was confirmed. The fragment was blunted and NotI (dephosphorylated) and SalI sites of pME18Sfϩ(ϩori P).
then inserted into the NruI site of the transfer vector pBm4 This library contained 1.2ϫ10 6 independent clones, 68% of (25). Genomic DNA of wild-type BmNPV and pBm4-pMCP (2 which had inserts with a mean size of 1.5 kb.
µg each) were co-transfected into BmN4 cells by lipofection (Gibco/BRL). Four days after co-transfection, the culture Cloning of a porcine complement regulatory protein cDNA supernatant was collected and recombinant viruses, in which the polyhedrin gene was replaced with soluble pMCP, were JY25 cells (10 8 ) were transfected with 100 µg of library cloned by the limiting dilution (24) . plasmids by electroporation at 960 µF and 250 V, and then About 10 5 p.f.u. of the recombinant virus (50 µl) was injected cultured. After selection with hygromycin B (400 µg/ml) for s.c. into fifth instar larva of the silkworm (Kanebo Silk, Aichi, 10 days, transfected cells were incubated with pig serum to Japan). Four days later, hemolymph was collected from select cells that acquired resistance to pig complement. Cells abdominal legs into a polypropylene tube placed on ice as (2ϫ10 8 ) were incubated at 37°C for 2 h with 200 ml of described (26) . Dithiothreitol was added to a final concentraDulbecco's modified Eagle's medium (DMEM) containing 10% tion of 5 mM to prevent melanization of the hemolymph. FCS, 10% pig serum as a source of complement and 1%
Hemocytes and cell debris were removed by centrifugation ascites of complement-activating anti-HLAI mouse mAb, as at 10,000 g for 10 min, then the supernatant was dialyzed well as mAb to human MCP (0.05% ascites of M-75) and DAF against 20 mM Tris-HCl (pH 7.4)-0.15 M NaCl at 4°C and (6.7 µg/ml each of IA10, IIH6 and VIIIA7) (21) , to eliminate stored at -80°C. the influence of the human complement regulatory proteins.
The dialyzed hemolymph (50 ml) was applied to a column Cells that survived were cultured to obtain 10 7 cells. Selection (0.56ϫ5 cm) of Sepharose conjugated with an anti-Myc using pig complement and expansion were repeated twice.
antibody (9E10) equilibrated with 20 mM Tris-HCl (pH 7.4)-After three rounds of selection, plasmids were rescued from 0.15M NaCl-0.05% NP-40. The column was washed with the the collected cells by Hirt extraction (22) and transformed same buffer and rspMCP was eluted with glycine buffer (pH into Escherichia coli DH10B by electroporation (18). The 3.0) (17). The eluate was immediately neutralized with 3 M plasmids were classified into 10 groups according to their Tris-HCl (pH 9) and applied to a MonoQ column (1 ml) insert sizes. Their activities were assessed by transfection equilibrated with 20 mM Tris-HCl (pH 7.6)-20 mM NaCl. The into JY25 cells and by incubation with antibody and pig column was eluted with a linear salt gradient to 500 mM for complement 2 days later. One plasmid with an insert of 1.4 50 min (flow rate: 1 ml/min). rspMCP eluted at 200 mM NaCl kb conferred resistance to pig complement upon JY25 cells.
migrated as a single band on SDS-PAGE. Both strands were sequenced by dideoxy termination.
Cytotoxicity assay Northern blotting hybridization of pMCP mRNA
The poly(A) RNA was prepared from the total RNA (23) of the JY 25 cells (1ϫ10 7 ) were transfected with pMCP cDNA (15 µg) by electroporation at 960 µF and 250 V, and transfectants PAE cells and blotted against 1.4 kb full length pMCP cDNA probe. The probe was radiolabeled with High Prime (Boehrwere selected with hygromycin B (400 µg/ml). Cells (1ϫ10 5 ) were washed twice with PBS(-), suspended in 50 µl DMEM inger Mannheim, Mannheim, Germany) and the Rapid-hyb buffer (Amersham Life Science, Buckinghamshire, UK) was and mixed with 50 µl of a solution containing 1 µl of anti-HLAI mAb (W6/32) ascites, 0.1 µl of anti-human MCP mAb (M-75) used for hybridization. ascites, 667 ng each of anti-human DAF mAb IA10, IIH6 and VIIIA7, and 10 µl of porcine serum or heat inactivated porcine serum. The mixtures were incubated for 2 h at 37°C and the number of living cells was measured by the Trypan blue dye exclusion method.
Assay of factor I cofactor activity of rspMCP Human C3b was generated from C3 (27) by cleavage with trypsin (28) and labeled with Na-125 I (Amersham International, at 37°C. A much less amount of C3b was used per assay than usual to save the labeled C3b. The positive control for the cofactor was human factor H (44 µg/ml) (30) . Cleavage were repeated twice with an increasing of survival rate. After of the αЈ chain of C3b was assessed by SDS-PAGE under the first, second and third selection and culture, the survival reducing conditions followed by autoradiography.
rates were 0.1, 6 and 20% respectively, indicating the efficient Preparation of mAb to pMCP and FACS analysis enrichment of cells resistant to pig complement. Plasmids rescued from cells after the third selection and Hybridomas were generated by fusing X63Ag8.653 myeloma culture were classified into 10 groups according to size cells with spleen cells from a BALB/c mouse immunized with and restriction profile (data not shown), then transfected rspMCP. Culture supernatants were tested for anti-pMCP individually into JY25 cells. One clone with a 1.4 kb insert activity by ELISA using rspMCP. Two clones (pMCP6 and conferred resistance to pig complement. The transfectants pMCP7) were isolated, both of which were of the IgG1 isotype.
were completely resistant to 10% pig serum, whereas Ͼ90% FACS analysis was performed in a FACScan cytometer of non-transfected cells were killed (Fig. 1) . The nucleotide (Becton Dickinson, Mountain View, CA) with the Cell Quest sequence of this cDNA had the highest identity with human program.
MCP, so we termed it pMCP (see below).
Structural properties of pMCP Results
The pMCP cDNA consisted of 1341 bp, not including a Expression cloning of pMCP poly(A) tail and it encoded a predicted protein of 363 amino acids (Fig. 2) . It had the highest amino acid identity to human We obtained cDNAs of a membrane-bound pig complement regulatory protein by expression cloning. Human cells trans-MCP (42%) among all proteins in the data bases and had a similar domain organization to that of human MCP, consisting fected with a pig cDNA library were incubated with antibody plus pig complement, then plasmids were rescued from the of a signal peptide, four short consensus repeats (SCR), and serine-, threonine-and proline-rich (STP), transmembrane surviving cells. The recipient for a cDNA library constructed in a mammalian expression vector bearing ori P was the (TM), and cytoplasmic (CYT) domains (Fig. 2) . The CYT domain of pMCP had only 12 residues, which is four residues EBNA-1-expressing cell line, JY25. These cells had high transfection efficiency (Ͼ50%) and the combination with ori shorter than the shorter CYT domain of human MCP (32) . pMCP has two putative N-glycosylation sites (Fig. 2) , whereas P allowed stable maintenance of episomal plasmids that enabled efficient plasmid rescue. The source of mRNA for human MCP has three (32) . Figure 3 shows a comparison of the amino acid sequences the cDNA library was the porcine endothelial PAE cell line, because vascular endothelium is a site of high expression of of pMCP and the B1 isoform of human MCP (32) . Sixteen cysteine residues in four SCR are conserved in both species. complement regulatory proteins.
Incubating JY25 cells for 2 h at 37°C with a saturating Among four SCR, the fourth had the highest amino acid identity (63%) and the first had the lowest (38%). The STP concentration of anti-HLAI antibody and 10% pig serum killed only 50% of cells, suggesting that human complement and TM domains had only 23 and 35% amino acid identities respectively. regulatory proteins had some protective activity (data not shown). Adding saturating concentrations of anti-DAF and RT-PCR analysis of the 3Ј region of pMCP mRNA in the PAE cell line demonstrated two transcripts at similar expresanti-MCP antibodies to the incubation mixture resulted in complete killing (Ͻ0.1% survival). Anti-CD59 had no effect sion levels (data not shown). Sequencing indicated that one corresponded to the cloned cDNA and that the other lacked (data not shown).
For cloning, JY25 cells (10 8 ) transfected with the cDNA 51 nucleotides (nucleotides 990-1040) within the STP domain (Fig. 2) . Since the boundaries of this 51 nucleotide region had library were selected with hygromycin B and 10 days later were incubated with pig complement under similar conditions. the features of exon boundaries, this region may correspond to an exon and the shorter transcript may be an alternative The surviving cells were cultured until the original number of cells was obtained. Selection by complement and culture splicing product. Northern blot analysis of the pMCP mRNA in the PAE cells Expression of pMCP on blood cells and endothelial and epithelial cells as assessed by anti-pMCP mAb demonstrated a major band of~4 kb (Fig .4) . There was no signal in a region of 1.3-1.5kb corresponding to the cloned To confirm the specificity of anti-pMCP mAb pMCP6 and cDNA, indicating that it was derived from a minor transcript. pMCP7, we stained JY25 cells transfected or not with pMCP cDNA. As shown in Fig. 6(A) , both mAb stained JY25 cells Factor I cofactor activity of pMCP transfected with pMCP cDNA but not those with a control plasmid, indicating that these antibodies specifically recogTo demonstrate the factor I cofactor activity of pMCP, we nize pMCP and that they recognize native, cell-bound pMCP. prepared a recombinant soluble form of pMCP (termed We then stained PAE cells and cells of a pig kidney epithelial rspMCP) using the baculovirus system. Since pig C3b and cell line LLC-PK1 (Fig. 6B ). PAE and LLC-PK1 expressed factor I were not available, we used human C3b and factor I. similar levels of pMCP. We next stained pig blood cells (Fig.  rspMCP functioned as a cofactor even in this heterologous 6C). Virtually all leukocytes (buffy coat cells) and erythrocytes combination, supporting complete cleavage of the C3b αЈ expressed pMCP. Leukocytes expressed~10 times less chain into the αЈ-65 and αЈ-43 chain (Fig. 5A, lane 7) similarly pMCP as PAE cells and 10 times more than erythrocytes. to human factor H (Fig. 5A, lane 3) . When cofactor activities Therefore, pMCP is widely expressed on blood cells, vascular of rspMCP and human factor H were compared under the endothelial cells and kidney epithelial cells, supporting the conditions that cause partial cleavage of the C3b αЈ-chain, notion that it protects host cells from complement. rspMCP had similar or slightly less activity than human factor H (Fig. 5B, lanes 3 and 7) . Therefore, pMCP has factor I Discussion cofactor activity. Notably the size of a smaller product made with rspMCP was 46 kDa, indicating that the release of C3f
We cloned a structural and functional pig homologue of MCP (CD46) called pMCP. We then prepared recombinant soluble fragment did not occur under these conditions (lane7). (100 ng/ml) was incubated with various combinations of human with a radiolabeled pMCP cDNA probe (1.4 kb). Positions of 28S and factors I (14 µg/ml) and H (44 µg/ml), or rspMCP (10 µg/ml) in 20 µl 18S ribosomal RNA were indicated.
of DGVB ϩϩ at 37°C for 2.5 (A) or 1 (B) h. The samples were resolved by SDS-PAGE under reducing conditions and visualized by autoradiography. Lanes 1, factor I alone; lanes 2, factor H alone; lanes 3, factors I and H; lanes 4, buffer alone; lanes 5, rspMCP alone; pMCP protein and generated mAb to it. The deduced pMCP lanes 6, factor I alone; lanes 7, rspMCP plus factor I.
protein contained 363 amino acids and had a domain organization similar to human MCP: a signal peptide, four SCR, and STP-rich, TM and short CYT domains. The overall amino acid identity to human MCP was 42%, which was the highest complement. rspMCP showed factor I cofactor activity in cleaving C3b. Therefore, pMCP is also functionally homologamong all known proteins. The fourth SCR with a C3b binding site in human MCP had the highest amino acid identity of ous to MCP. Northern blotting analysis demonstrated only a single pMCP 63%, indicating that pMCP is structurally homologous to human MCP. Transfection of pMCP cDNA into the human B mRNA of 4 kb in the PAE cells (Fig. 4) . A band corresponding to the cloned cDNA (1.4 kb) was not seen, indicating that it lymphoblastoid cell line JY25 conferred resistance to pig corresponded to a minor transcript that was cloned preferenthan PAE cells. This widespread expression of pMCP in pig blood is consistent with the notion that pMCP plays a role tially due to its short length. It is likely that the major pMCP mRNA has much longer untranslated regions. A major mRNA similar to that of human MCP in protecting cells from complement. of human MCP is also of~4 kb and cloned human MCP cDNA are of 1.5-1.6 kb (33) (34) (35) . Thus, pMCP has a similar Recently, a structural homologue of MCP was cloned in the guinea pig (40). In contrast to human and pig MCP, the profile of transcripts to human MCP.
Human MCP is widely expressed on various cells in the guinea pig MCP transcript is expressed only in the testis. Guinea pig MCP would thus have a specific function in body where it protects them from autologous complement (36) . MCP is also expressed on sperm (37 results (7, 48) . Another means of inhibiting the activation of
